Delivery Order SPE2DB20D2014-SPE2DB25FC63T
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at approximately $27,938 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) on August 25, 2025, with completion targeted for August 26, 2025. This non-set-aside, competitively awarded delivery order reflects a firm fixed-price contract structure and will be performed at the vendor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication...
- The Defense Logistics Agency awarded a $6,014.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 mg CellCept tablets (500 count) on June 4, 2025, with completion expected by June 5, 2025. This non-set-aside contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly used in military and veteran healthcare systems for organ transplant recipients and certain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $9,754.64. This firm fixed-price delivery order, issued on August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for CellCept 500 mg tablets (500-count packages) valued at $12,029.30 under a firm fixed-price contract type. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026. CellCept (mycophenolate mofetil) is an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,577.14 to AmerisourceBergen Drug Corp for the supply of CellCept 250 mg capsules (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly...
- The Defense Logistics Agency awarded a delivery order valued at $8,717.35 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count) on September 10, 2025, with completion scheduled for September 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) valued at $7,854.18. The award was made on May 6, 2025, with an ultimate completion date of May 7, 2025, under a firm fixed-price delivery order arrangement. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $31,318.38 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) under a firm fixed price contract. The award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical...
- The Defense Logistics Agency awarded a $13,249.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count units). The contract was competitively awarded without set-aside designation and is set for completion by September 16, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $27,735.62 and carries no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC63TDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,024.78 to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly used in military and veteran healthcare settings for transplant rejection prevention and autoimmune conditions. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a $999.9 billion prime pharmaceutical supply vehicle running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor with an extensive portfolio of competitively awarded contracts through the DLA Medical Supply Chain, demonstrating significant capability to fulfill federal medical procurement requirements for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 8/4/25 |